SuPAR in major depression: Association with 26 weeks antidepressant response and 10-year depression outcomes

SuPAR in major depression: Association with 26 weeks antidepressant response and 10-year depression outcomes

Introduction: Inflammation has been associated with depression and differential antidepressant (AD) treatment response. Soluble urokinase plasminogen activator receptor (suPAR) is a novel measure of chronic inflammation. We investigated whether suPAR is associated with depression severity and AD res...

Full description

Bibliographic Details
Main Authors: T.H. Haupt, B. Elfving, J. Eugen-Olsen, O. Mors, O. Köhler-Forsberg
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:Brain, Behavior, & Immunity - Health
Subjects:
Inflammation
Immunology
Depression
Psychiatry
Treatment
Clinical study
Online Access:http://www.sciencedirect.com/science/article/pii/S2666354623000996

Internet

http://www.sciencedirect.com/science/article/pii/S2666354623000996

Similar Items